Only subtle protein conformational adaptations are required for ligand binding to thyroid hormone receptors:

Leandro Martínez1, Igor Polikarpov, Munir S Skaf

  • 1Institute of Chemistry, State University of Campinas-UNICAMP, P.O. Box 6154, Campinas, SP, 13084-862, Brazil.

Insights

This study reveals that thyroid hormone receptors (TR) bind ligands through simple diffusion and gentle protein movements, not large conformational changes. This finding offers new insights into nuclear receptor function and drug development.

Area of Science:

  • Molecular Biology
  • Biophysics
  • Computational Chemistry

Background:

  • Thyroid hormone receptors (TR) are crucial transcription regulators impacting health, development, and metabolism.
  • Malfunctioning TRs are linked to diseases like diabetes, obesity, and cancer, often due to impaired ligand binding.
  • Understanding ligand binding and dissociation is key for TR function and pharmaceutical development.

Purpose of the Study:

  • To computationally investigate ligand entry into the ligand binding domain (LBD) of nuclear receptors, specifically TRs.
  • To explore the mechanisms of ligand binding and dissociation in nuclear receptors using advanced simulation techniques.
  • To challenge existing models by proposing an alternative mechanism for ligand interaction with TRs.

Main Methods:

  • Utilized a generalized steered molecular dynamics technique for single-molecule pulling simulations.
  • Simulated ligand binding to thyroid hormone receptors (TRs) along nonlinear pathways.
  • Analyzed protein movements and conformational adaptations during ligand entry into the LBD.

Main Results:

  • Demonstrated that ligand entry into the TR LBD requires only gentle protein movements and conformational adaptations.
  • Quantified the forces involved in ligand binding, finding them comparable to those in ligand dissociation.
  • Proposed that ligands can diffuse through the protein surface to reach the binding pocket, challenging existing models.

Conclusions:

  • Ligand binding and dissociation in nuclear receptors may occur via a simpler mechanism involving diffusion and minor protein adjustments.
  • Large-amplitude protein motions, previously suggested, may not be essential for ligand entry.
  • This revised model reconciles conformational changes with existing nuclear receptor structures, offering new avenues for drug design.

Related Concept Videos

Synthesis and Regulation of Thyroid Hormones01:20

Synthesis and Regulation of Thyroid Hormones

Low blood levels of the thyroid hormones — triiodothyronine (T3) and thyroxine (T4) — signal the hypothalamus to release the thyrotropin-releasing hormone (TRH). TRH then reaches the pituitary gland and stimulates the release of thyroid-stimulating hormone(TSH) into the bloodstream.
Upon reaching the thyroid gland, TSH stimulates the follicular cells' active uptake of iodide ions from the blood. The ions diffuse to the apical surface of the cells and are oxidized to iodine. The iodine is then...
Ligand Binding Sites02:40

Ligand Binding Sites

Proteins are dynamic macromolecules that carry out a wide variety of essential processes; however, the activities of most proteins depend on their interactions with other molecules or ions, known as ligands.
Protein-ligand interactions are quite specific; even though numerous potential ligands surround a cellular protein at any given time, only a particular ligand can bind to that protein. Moreover, a ligand binds only to a dedicated area on the surface of the protein, known as the...
Conserved Binding Sites01:49

Conserved Binding Sites

Many proteins’ biological role depends on their interactions with their ligands, small molecules that bind to specific locations on the protein known as ligand-binding sites. Ligand-binding sites are often conserved among homologous proteins as these sites are critical for protein function.
Binding sites are often located in large pockets, and if their location on a protein’s surface is unknown, it can be predicted using various approaches. The energetic method computationally analyses the...
Cooperative Allosteric Transitions01:58

Cooperative Allosteric Transitions

Cooperative allosteric transitions can occur in multimeric proteins, where each subunit of the protein has its own ligand-binding site. When a ligand binds to any of these subunits, it triggers a conformational change that affects the binding sites in the other subunits; this can change the affinity of the other sites for their respective ligands. The ability of the protein to change the shape of its binding site is attributed to the presence of a mix of flexible and stable segments in the...
Cooperative Allosteric Transitions01:58

Cooperative Allosteric Transitions

Cooperative allosteric transitions can occur in multimeric proteins, where each subunit of the protein has its own ligand-binding site. When a ligand binds to any of these subunits, it triggers a conformational change that affects the binding sites in the other subunits; this can change the affinity of the other sites for their respective ligands. The ability of the protein to change the shape of its binding site is attributed to the presence of a mix of flexible and stable segments in the...
Ligand Binding and Linkage00:49

Ligand Binding and Linkage

Allosteric proteins have more than one ligand binding site; the binding of a ligand to any of these sites influences the binding of ligands to the other sites. When a protein is allosteric, its binding sites are called coupled or linked.  In the case of enzymes, the site that binds to the substrate is known as the active site and the other site is known as the regulatory site. When a ligand binds to the regulatory site, this leads to conformational changes in the protein that can influence the...